Friday - December 19, 2025
OHSU study: CAR-T therapy shows long-term survival for patients with lymphoma
December 11, 2025
PORTLAND, Oregon, Dec. 11 -- Oregon Health and Science University issued the following news:

* * *

OHSU study: CAR-T therapy shows long-term survival for patients with lymphoma

*

A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult patients with relapsed or refractory large B-cell lymphoma, even year . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products